Pulse Biosciences (PLSE) Depreciation & Amortization (CF) (2015 - 2025)

Pulse Biosciences' Depreciation & Amortization (CF) history runs 11 years deep, the most recent figure standing at $93000.0 for Q4 2025.

• On a quarterly basis, Depreciation & Amortization (CF) fell 23.14% year-over-year to $93000.0 in Q4 2025; TTM through Dec 2025 was $410000.0, a 2.61% decrease from a year earlier, with the FY2025 full-year figure at $406000.0, down 20.7% from the prior year.
• Depreciation & Amortization (CF) fell to $93000.0 in Q4 2025 per PLSE's latest filing, from $100000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $200000.0 in Q3 2022 and bottomed at $93000.0 in Q4 2025.
• The 5-year median for Depreciation & Amortization (CF) is $100000.0 (2021), against an average of $116100.0.
• Across the five-year window, Depreciation & Amortization (CF) jumped 100.0% in 2022 and sank 50.0% in 2023, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $131000.0 in 2021, then jumped by 52.67% to $200000.0 in 2022, then sank by 50.0% to $100000.0 in 2023, then increased by 21.0% to $121000.0 in 2024, then retreated by 23.14% to $93000.0 in 2025.
• Per Business Quant, the three latest PLSE Depreciation & Amortization (CF) figures stand at $93000.0 (Q4 2025), $100000.0 (Q3 2025), and $100000.0 (Q2 2025).